[1]
Mucenic, M. et al. 2019. Sofosbuvir, ribavirin and pegylated interferon for a daclatasvir-resistent genotype 3 hepatitis C virus: case report and review. Revista do Instituto de Medicina Tropical de São Paulo. 61, (Feb. 2019), e12. DOI:https://doi.org/10.1590/S1678-9946201961012.